Par Pharmaceutical, headquartered in Chestnut Ridge, NY, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life. Par, among the top leaders in the U.S. generics industry, possesses a portfolio that includes sterile injectables, alternative dosage forms and many other differentiated products. Par is advancing a research and development (R&D) pipeline of approximately 200 potential new products. Par is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization. Learn more at www.endo.com
quality you can depend on
High-quality and cost-effective products with the highest level of customer service.
facilities & manufacturing
Learn more about our state of the art facilities, distribution center, and our manufacturing & packaging capabilities.
our generics products
We offer an extensive range of prescription and over-the-counter products across a wide range of therapeutic areas.